Your browser doesn't support javascript.
loading
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models.
Chiorazzi, Alessia; Wozniak, Krystyna M; Rais, Rana; Wu, Ying; Gadiano, Alexandra J; Farah, Mohamed H; Liu, Ying; Canta, Annalisa; Alberti, Paola; Rodriguez-Menendez, Virginia; Meregalli, Cristina; Fumagalli, Giulia; Monza, Laura; Pozzi, Eleonora; Vornov, James J; Polydefkis, Michael; Pietra, Claudio; Slusher, Barbara S; Cavaletti, Guido.
Afiliação
  • Chiorazzi A; Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy.
  • Wozniak KM; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
  • Rais R; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
  • Wu Y; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
  • Gadiano AJ; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
  • Farah MH; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
  • Liu Y; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Neuromuscular Medicine and Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
  • Canta A; Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy.
  • Alberti P; Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy; PhD Program in Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy.
  • Rodriguez-Menendez V; Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy.
  • Meregalli C; Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy.
  • Fumagalli G; Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy; PhD Program in Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy.
  • Monza L; Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy; PhD Program DIMET, University of Milano-Bicocca, 20900 Monza, Italy.
  • Pozzi E; Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy; PhD Program in Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy.
  • Vornov JJ; Medpace, Cincinnati, OH 45227, USA.
  • Polydefkis M; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Neuromuscular Medicine and Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
  • Pietra C; Helsinn Healthcare SA, 6915 Lugano, Switzerland.
  • Slusher BS; Johns Hopkins Drug Discovery, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Neuroscience, Medicine, Psychiatry and Oncology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. El
  • Cavaletti G; Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, 20900 Monza, Italy. Electronic address: guido.cavaletti@unimib.it.
Eur J Pharmacol ; 840: 89-103, 2018 Dec 05.
Article em En | MEDLINE | ID: mdl-30268665

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Derivados de Benzeno / Fármacos Neuroprotetores / Grelina / Sistema Nervoso / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Derivados de Benzeno / Fármacos Neuroprotetores / Grelina / Sistema Nervoso / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article